Clinical Trials Browser

Interventional × Breast Neoplasms × Abiraterone Acetate × Clear all

NCT03568656 2025-08-08

Study to Evaluate CCS1477 in Advanced Tumours

Phase 1/2 Completed

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01517802 2022-05-10

A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate

Phase 3 Completed

32 enrolled 7 charts

Breast Neoplasms

NCT01842321 2021-02-23

AMA

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT01381874 2019-04-11

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Phase 2 Completed

297 enrolled 19 charts

Breast Neoplasms, Neoplasm Metastasis

NCT01814865 2013-12-20

Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms